Stratégies actuelles du dépistage de la trisomie 21: rôle du laboratoire

Bartels, 1988, Maternal levels of pregnancy-specific β1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome, Hum. Genet., 80, 465, 10.1007/BF00451454 Bogart, 1987, Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosomal abnormalities, Prenat. Diagn., 7, 623, 10.1002/pd.1970070904 Canick, 1988, Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome, Br. J. Obstet. Gynaecol., 95, 330, 10.1111/j.1471-0528.1988.tb06601.x Cuckle, 1992, hCG, estriol and other maternal blood markers of fetal aneuploidy Cuckle, 1992, hCG, estriol and other maternal blood markers of aneuploidy, 327, 588 Cuckle, 1988, First trimester bio-chemical screening for Down syndrome, Lancet, ii, 851, 10.1016/S0140-6736(88)92816-4 Cuckle, 1990, The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepi androsterone sulphate levels, Br. J. Obstet. Gynaecol., 97, 272, 10.1111/j.1471-0528.1990.tb01794.x Cuckle, 1990, Measurement of activity of ureas resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome, Br. Med. J., 301, 1024, 10.1136/bmj.301.6759.1024 Goncalves, 1994, The accuracy of prenatal ultrasonography in detecting congenital anomalies, Am. J. Obstet. Gynecol., 171, 1606, 10.1016/0002-9378(94)90411-1 Knight, 1989, Maternal serum level of placental products hCG, hPL, SP1 and progesterone are all elevated in cases of fetal Down syndrome, Am. J. Hum. Genet., 45, A 263 Lynch, 1989, Ultrasound detection of Down syndrome: Is it really possible?, Obstet. Gynecol., 73, 267 Macri, 1990, Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotrophin, Am. J. Obstet. Gynecol., 163, 1248, 10.1016/0002-9378(90)90700-H Merkatz, 1984, An association between low maternal serum alpha-fœtoprotein and fetal chromosome abnormalities, Am. J. Obstet. Gynecol., 148, 886, 10.1016/0002-9378(84)90530-1 Muller, 1993, Prospective maternal serum hCG screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal death, Prenat. Diagn., 13, 29, 10.1002/pd.1970130106 Muller, 1990, A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome, Prenat. Diagn., 10, 389, 10.1002/pd.1970100606 Muller, 1994, Do racial differences exist in second-trimester maternal hCG levels? A study of 23 969 patients, Prenat. Diagn., 14, 633, 10.1002/pd.1970140721 Muller, 1992, Spécifications du réactif hCG pour le dépistage anténatal de la trisomie 21, Immunoanal. Biol. Spec., 33, 39 Pranav, 1994, First-trimester fetal nuchal translucency thickness and risk for trisomies, Obstet. Gynecol., 84, 420 Wald, 1988, Maternal serum screening for Down's syndrome in early pregnancy, Br. Med. J., 297, 883, 10.1136/bmj.297.6653.883